Introductory comments to Symposium in Writing: inhibitors of immunosurveillence and anti-tumor immunity Suzanne Ostrand-Rosenberg Symposium in Writing 30 October 2003 Pages: 63 - 63
Derangement of immune responses by myeloid suppressor cells Paolo SerafiniCarmela De SantoVincenzo Bronte Symposium in Writing 30 October 2003 Pages: 64 - 72
Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells Wei-Zen WeiGerald P. MorrisYi-chi M. Kong Symposium in Writing 11 November 2003 Pages: 73 - 78
Role of IL-13 in regulation of anti-tumor immunity and tumor growth Masaki TerabeJong Myun ParkJay A. Berzofsky Symposium in Writing 11 November 2003 Pages: 79 - 85
Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic disease Suzanne Ostrand-RosenbergPratima SinhaErika Danna Symposium in Writing 30 October 2003 Pages: 86 - 91
Immunization with a plant-produced colorectal cancer antigen Thorsten VerchD. Craig HooperHilary Koprowski Original Article 18 October 2003 Pages: 92 - 99
T-cell responses to multiple antigens presented by RNA-transfected APCs: a possible immunomonitoring tool Shirley M. BartidoKaren Zier Original Article 09 September 2003 Pages: 100 - 109
Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma Reiko F. IrieDavid W. OllilaDonald L. Morton Original Article 16 October 2003 Pages: 110 - 117
In vitro biological activities of transmembrane superantigen staphylococcal enterotoxin A fusion protein Wenxue MaHai YuHongchuan Jin Original Article 22 October 2003 Pages: 118 - 124
Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma Peter HerseyScott W. MenziesMargaret Lett Original Article 05 November 2003 Pages: 125 - 134
